Merrill offered fee waivers on certain new-issue products when purchased in advisory accounts.
Reps recommended clients buy the products in brokerage accounts, making them ineligible for waivers, and then move them to advisory accounts, FINRA says.
Merrill's failures to spot or prevent this conduct violated Reg BI, according to the regulator.